FHIT gene abnormalities in both benign and malignant thyroid tumours.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Cancer

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0959-8049(98)00370-0PMID 10448301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Structure and expression of the human FHIT gene in normal and tumor cells.

  1997cited by this paper
• FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

  1997cited by this paper
• Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.

  1997cited by this paper
• Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.

  1997cited by this paper
• Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss

  1997cited by this paper
• Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.

  1996cited by this paper
• Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.

  1996cited by this paper
• The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.

  1996cited by this paper
• Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.

  1996cited by this paper
• The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer

  1996cited by this paper
• The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

  1996cited by this paper
• The FHIT gene at 3p14.2 is abnormal in breast carcinomas.

  1996cited by this paper
• Aberrant FHIT transcripts in Merkel cell carcinoma.

  1996cited by this paper
• Infrequent CDKN2 mutation in human differentiated thyroid cancers

  1996cited by this paper
• FHIT gene alterations in head and neck squamous cell carcinomas.

  1996cited by this paper
• The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis

  1995cited by this paper
• Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family.

  1995cited by this paper
• Genetics of follicular thyroid cancer.

  1995cited by this paper
• Molecular basis of thyroid cancer.

  1994cited by this paper
• Characterization of the HeLa cell DNA polymerase alpha-associated Ap4A binding protein by photoaffinity labeling.

  1994cited by this paper
• High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.

  1993cited by this paper
• p53 mutations in all stages of thyroid carcinomas.

  1993cited by this paper
• The HIT protein family: a new family of proteins present in prokaryotes, yeast and mammals.

  1992cited by this paper
• Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.

  1992cited by this paper
• High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.

  1991cited by this paper
• Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.

  1991cited by this paper
• Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

  1991cited by this paper
• PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

  1990cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.

  1989cited by this paper
• Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation.

  1989cited by this paper
• Drastic rise of intracellular adenosine(5')tetraphospho(5')adenosine correlates with onset of DNA synthesis in eukaryotic cells.

  1984cited by this paper

• Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives

  2021cites this paper
• Genetic Characterization and Identification of Novel Treatment Targets in Anaplastic Thyroid Carcinoma

  2019cites this paper
• Genetic Polymorphism Predisposing to Differentiated Thyroid Cancer: A Review of Major Findings of the Genome-Wide Association Studies

  2018cites this paper
• Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines.

  2017cites this paper
• Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer

  2017cites this paper
• Biología molecular del carcinoma de tiroides de estirpe folicular. Bases moleculares en la oncogénesis tiroidea

  2017cites this paper
• Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors

  2014cites this paper
• Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir.

  2011cites this paper
• Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.

  2010cites this paper
• Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma

  2010cites this paper
• Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.

  2010cites this paper
• Association between Decreased WWOX Protein Expression and Thyroid Cancer Development

  2007cites this paper
• Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.

  2006influential citation
• S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma

  2005cites this paper
• Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.

  2005cites this paper
• Molecular Prognosticators and Genomic Instability in Papillary Thyroid Cancer

  2005cites this paper
• Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk.

  2004cites this paper
• P53 and other cell cycle regulators.

  2004cites this paper
• Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma

  2003cites this paper
• Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands

  2003cites this paper
• [Update on differenciated thyroid carcinoma].

  2002cites this paper
• Functionally impaired TR mutants are present in thyroid papillary cancer.

  2002cites this paper
• Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.

  2002cites this paper
• Abnormal FHIT gene transcript and c-myc and c-erbB2 amplification in breast cancer.

  2002cites this paper
• Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53−/− mice

  2001influential citation
• Molecular pathogenesis of thyroid nodules and cancer.

  2000cites this paper
• Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.

  2000cites this paper